Candriam Equities L Oncology Impact, N - Capitalisation/ LU2346866317 /
| NAV10/06/2024 | Chg.+1.0100 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 159.3800EUR | +0.64% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | - | - | 1.59 | -2.53 | 0.81 | 3.41 | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | -% | -% | -% | -% | -% |
| Sharpe ratio | - | - | - | - | - |
| Best month | +3.41% | +3.41% | +3.41% | - | - |
| Worst month | -2.53% | -2.53% | -2.53% | - | - |
| Maximum loss | - | - | - | - | - |
| Outperformance | - | - | - | - | - |
All quotes in EUR
Share classes
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Oncology Imp... | reinvestment | 2,397.3999 | +7.95% | +1.59% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,561.9700 | +8.09% | +1.97% | |
| Candriam Equities L Oncology Imp... | reinvestment | 207.2800 | +4.43% | -8.91% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,240.0901 | +5.85% | +11.92% | |
| Candriam Equities L Oncology Imp... | paying dividend | 1,608.6000 | +7.61% | +0.61% | |
| Candriam Equities L Oncology Imp... | reinvestment | 247.9700 | +6.73% | +10.91% | |
| Candriam Equities L Oncology Imp... | paying dividend | 235.7400 | +6.60% | -2.17% | |
| Candriam Equities L Oncology Imp... | paying dividend | 190.9900 | +7.51% | +0.32% | |
| Candriam Equities L Oncology Imp... | paying dividend | 20,703.0000 | +3.07% | -2.20% | |
| Candriam Equities L Oncology Imp... | reinvestment | 158.4700 | +5.73% | +11.54% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,108.6599 | +5.41% | -6.30% | |
| Candriam Equities L Oncology Imp... | reinvestment | 262.8800 | +7.63% | +13.75% | |
| Candriam Equities L Oncology Imp... | reinvestment | 206.7100 | +4.01% | -9.99% | |
| Candriam Equities L Oncology Imp... | reinvestment | 286.3900 | +7.50% | +0.31% | |
| Candriam Equities L Oncology Imp... | reinvestment | 193.6600 | +5.30% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 1,848.0400 | +6.19% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,881.3601 | +8.28% | +3.83% | |
| Candriam Equities L Oncology Imp... | reinvestment | 159.3800 | - | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 274.1100 | +7.27% | +0.94% |
Performance
| YTD | - | ||
|---|---|---|---|
| 6 Months | - | ||
| 1 Year | - | ||
| 3 Years | - | ||
| 5 Years | - | ||
| 10 Years | - | ||
| Since start | +4.48% | ||
| Year | |||
